Log In
BCIQ
Print this Print this
 

Dex-IN, dexmedetomidine

  Manage Alerts
Collapse Summary General Information
Company Recro Pharma Inc.
DescriptionIntranasal formulation of dexmedetomidine, an adrenergic receptor alpha 2 (ADRA2) agonist
Molecular Target Adrenergic receptor alpha 2 (ADRA2)
Mechanism of ActionAdrenergic receptor alpha 2 (ADRA2) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat peri-procedural pain; Treat postoperative pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today